Abstract
Kidney injury molecule‐1 (KIM‐1) is a type I transmembrane glycoprotein that is rapidly upregulated at the gene and protein level following various types of injury to the kidney. KIM‐1 expression is increased not only in acute and chronic kidney injury diseases but also in renal cell carcinoma. It may play an important role in carcinoma process. Caveolin‐1, the principal component of caveolae, is regarded as an important inhibitor of multiple signaling molecules. The cytokine transforming growth factor‐β1 (TGF‐β1) has been extensively studied in tumor biology and is believed to serve a variety of functions in tumor progression. In this study, we investigated the regulatory mechanism of TGF‐β1 on KIM‐1 and caveolin‐1 expression in 769‐P cells, a human renal cell adenocarcinoma cell line. Western blot analysis indicated that TGF‐β1 treatment resulted in a downregulation of KIM‐1 and an upregulation of caveolin‐1 in 769‐P cells. Specific knockdown of Smad3 with siRNAs significantly increased basal KIM‐1 expression and attenuated TGF‐β1‐induced KIM‐1 down regulation, which was associated with increased activation of extracellular signal‐regulated kinase (ERK) 1/2 and signal transducer and activator of transcription 3 (STAT3) signaling pathways. Interestingly, pre‐treatment of 769‐P cells with ERK inhibitor U0126 abolished TGF‐β1‐induced caveolin‐1 upregulation and partially restored KIM‐1 protein level. We also observed a significant decrease in KIM‐1 in 769‐P cells administered with caveolin‐1 scaffolding domain peptides. Taken together, our data demonstrate that TGF‐β1 may differentially regulate KIM‐1 and caveolin‐1 expression in renal cancer cells via both Smad3 and ERK1/2 signaling pathways.Support or Funding InformationNIH SC1DK112151; NIH/NCRR/RCMI 8G12MD007602 & 8U54MD007588This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
